WO2000067723A3 - Darreichungsform zur applikation in körperöffnungen - Google Patents

Darreichungsform zur applikation in körperöffnungen Download PDF

Info

Publication number
WO2000067723A3
WO2000067723A3 PCT/DE2000/001512 DE0001512W WO0067723A3 WO 2000067723 A3 WO2000067723 A3 WO 2000067723A3 DE 0001512 W DE0001512 W DE 0001512W WO 0067723 A3 WO0067723 A3 WO 0067723A3
Authority
WO
WIPO (PCT)
Prior art keywords
applying
administration
body orifices
substances
orifices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2000/001512
Other languages
English (en)
French (fr)
Other versions
WO2000067723A2 (de
Inventor
Roland Bodmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP00943585A priority Critical patent/EP1178777A2/de
Priority to AU58028/00A priority patent/AU5802800A/en
Priority to DE10081194T priority patent/DE10081194D2/de
Publication of WO2000067723A2 publication Critical patent/WO2000067723A2/de
Publication of WO2000067723A3 publication Critical patent/WO2000067723A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Beschrieben ist eine Kapsel zur Applikation von Wirkstoffen, umfassend mindestens ein in wässrigen Flüssigkeiten lösliches und/oder rasch zerfallendes Makromolekül oder eine Mischung aus mindestens zwei dieser Stoffe, wobei die Kapsel in Körperöffnungen rasch zerfällt.
PCT/DE2000/001512 1999-05-10 2000-05-10 Darreichungsform zur applikation in körperöffnungen Ceased WO2000067723A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00943585A EP1178777A2 (de) 1999-05-10 2000-05-10 Darreichungsform zur applikation in körperöffnungen
AU58028/00A AU5802800A (en) 1999-05-10 2000-05-10 Form of administration for applying in body orifices
DE10081194T DE10081194D2 (de) 1999-05-10 2000-05-10 Darreichungsform zur Applikation in Körperöffnungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19922537.0 1999-05-10
DE1999122537 DE19922537A1 (de) 1999-05-10 1999-05-10 Darreichungsform zur Applikation in Körperöffnungen

Publications (2)

Publication Number Publication Date
WO2000067723A2 WO2000067723A2 (de) 2000-11-16
WO2000067723A3 true WO2000067723A3 (de) 2001-05-31

Family

ID=7908255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2000/001512 Ceased WO2000067723A2 (de) 1999-05-10 2000-05-10 Darreichungsform zur applikation in körperöffnungen

Country Status (4)

Country Link
EP (1) EP1178777A2 (de)
AU (1) AU5802800A (de)
DE (2) DE19922537A1 (de)
WO (1) WO2000067723A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114746D0 (en) * 2001-06-16 2001-08-08 Boots Co Plc Medicinal composition
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
US9254270B2 (en) 2002-10-01 2016-02-09 Banner Life Sciences Llc Enteric soft capsules
ES2500316T3 (es) 2002-10-01 2014-09-30 Banner Pharmacaps, Inc. Composición entérica para la fabricación de una cubierta de cápsula blanda
US20060275361A1 (en) * 2005-06-03 2006-12-07 Cadbury Adams Usa Llc. Rapidly dissolving gelatin compositions and products made therefrom
EP1991196B1 (de) 2006-03-03 2016-10-12 Fmc Corporation Verfahren und Vorrichtung zur Herstellung von Kapseln.
US9272123B2 (en) 2013-12-16 2016-03-01 Esther Gallant Device and method for inserting lubricating capsule
US10058447B2 (en) 2013-12-16 2018-08-28 Esther Gallant Lubricating condom
US9775814B2 (en) 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
CN104758271A (zh) * 2015-03-16 2015-07-08 中华生物科技有限公司 纤维素胶与红藻卡帕胶复配的植物空心胶囊及制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041665A2 (de) * 1980-06-05 1981-12-16 Shionogi & Co., Ltd. Medizinische Kapseln zur rektalen Verwendung
WO1987001034A1 (fr) * 1985-08-20 1987-02-26 R.P. Scherer Gmbh Capsules de gelatine et leur procede de fabrication
EP0315960A1 (de) * 1987-11-11 1989-05-17 Euro-Celtique S.A. Nifedipin enthaltende Kapsel zur sofortigen oralen Freisetzung
RU2102981C1 (ru) * 1996-07-31 1998-01-27 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав желатиновых масс для получения ректокапсул
WO1998005310A1 (fr) * 1996-08-02 1998-02-12 Hisamitsu Pharmaceutical Co., Inc. Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale
WO2000051573A1 (en) * 1999-03-01 2000-09-08 Banner Pharmacaps, Inc. Gum acacia substituted soft gelatin capsules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3664341A (en) * 1970-12-24 1972-05-23 Schmid Inc Julius Vaginal capsule
GB1552416A (en) * 1975-08-12 1979-09-12 Beecham Group Ltd Pharmaceutical compositions
JPS572218A (en) * 1980-06-05 1982-01-07 Shionogi & Co Ltd Capsule agent for rectal administration
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
KR880701098A (ko) * 1986-04-01 1988-07-25 로버어트 에이 아미테이지 메틸프레드니솔론/소디움 카르복시메틸 전분 정제 조성물
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
JPH03255024A (ja) * 1990-03-05 1991-11-13 Tokai Capsule Kk 口中易溶軟カプセル剤
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
MX9706062A (es) * 1995-02-08 1997-10-31 Yamanouchi Europ Bv FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041665A2 (de) * 1980-06-05 1981-12-16 Shionogi & Co., Ltd. Medizinische Kapseln zur rektalen Verwendung
WO1987001034A1 (fr) * 1985-08-20 1987-02-26 R.P. Scherer Gmbh Capsules de gelatine et leur procede de fabrication
EP0315960A1 (de) * 1987-11-11 1989-05-17 Euro-Celtique S.A. Nifedipin enthaltende Kapsel zur sofortigen oralen Freisetzung
RU2102981C1 (ru) * 1996-07-31 1998-01-27 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав желатиновых масс для получения ректокапсул
WO1998005310A1 (fr) * 1996-08-02 1998-02-12 Hisamitsu Pharmaceutical Co., Inc. Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale
WO2000051573A1 (en) * 1999-03-01 2000-09-08 Banner Pharmacaps, Inc. Gum acacia substituted soft gelatin capsules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199813, Derwent World Patents Index; Class A96, AN 1998-145336, XP002152906 *
DATABASE WPI Section Ch Week 199839, Derwent World Patents Index; Class B07, AN 1998-454918, XP002152905 *

Also Published As

Publication number Publication date
DE19922537A1 (de) 2000-11-16
WO2000067723A2 (de) 2000-11-16
EP1178777A2 (de) 2002-02-13
AU5802800A (en) 2000-11-21
DE10081194D2 (de) 2002-04-25

Similar Documents

Publication Publication Date Title
WO2005072079A3 (en) Drug coating providing high drug loading and methods for providing the same
WO2002101412A3 (en) Spray freeze-dried compositions
WO2001095899A3 (en) Pharmaceutical compositions comprising cannabidiol derivatives
HK1042444A1 (zh) 藥用噴霧製劑
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
WO2004026231A3 (en) Formulation for lipophilic agents
IE891032L (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
WO2001087329A8 (en) Liquid pharmaceutical composition containing an erythropoietin derivate
CA2345675A1 (en) Two chamber cartridge for atomizers
HK1046527A1 (zh) 金剛烷衍生物
WO2000007572A3 (de) Zweiteilige kapsel zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren
WO2002072073A3 (en) Pharmaceutical formulation comprising atorvastatin calcium
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2000067723A3 (de) Darreichungsform zur applikation in körperöffnungen
CA2497171A1 (en) Water stabilized medicinal aerosol formulation
WO2000010526A3 (en) New oral formulation for 5-ht4 agonists or antagonists
WO2001072264A3 (de) Pro-liposomal verkapselte zubereitungen (iv)
WO2002039997A3 (en) Ace-2 modulating compounds and use thereof
WO1997026867A3 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
WO2001030391A3 (en) Pharmaceutical composition containing midazolam
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
WO2001085165A3 (de) Kombination von liponsäure und c1-donoren zur behandlung von störungen des zentralen nervensystems

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000943585

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000943585

Country of ref document: EP

REF Corresponds to

Ref document number: 10081194

Country of ref document: DE

Date of ref document: 20020425

WWE Wipo information: entry into national phase

Ref document number: 10081194

Country of ref document: DE

WWW Wipo information: withdrawn in national office

Ref document number: 2000943585

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP